1. Combination chemotherapy of dacarbazine and fotemustine in disseminated malignant melanoma

   • Marie-Françoise Avril
   • Jean Bonneterre
   • Jean-Pierre Bizzari

   Original Articles Pages: 81 - 84

2. Combination salvage chemotherapy using cisplatin and teniposide for patients with refractory germinal testicular tumors

   • Toshihiko Kotake
   • Tsuneharu Miki

   Original Articles Pages: 85 - 88

3. Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(γ-l-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo

   • Takashi Tsuruo
   • Yojiro Sudo
   • Makoto Morimoto

   Original Articles Pages: 89 - 93

4. Inflammatory carcinoma of the breast: results of a combined-modality approach — M. D. Anderson Cancer Center experience

   • Eun H. Koh
   • Aman U. Buzdar
   • Gabriel N. Hortobagyi

   Original Articles Pages: 94 - 100

5. Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer

   • S. Lundgren
   • P. E. Lønning
   • S. Kvinnsland

   Original Articles Pages: 101 - 105

6. The comparative disposition of [¹⁴C]-fotemustine in non-tumourous and tumourous mice

   • R. M. J. Ings
   • M. Breen
   • D. B. Campbell

   Original Articles Pages: 106 - 110

7. Reaction kinetics of cisplatin and its monoaquated species with the (potential) renal protecting agents (di)mesna and thiosulfate

   • O. R. Leeuwenkamp
   • W. J. F. van der Vijgh
   • H. M. Pinedo

   Original Articles Pages: 111 - 114

8. A highly sensitive enzyme-linked immunosorbent assay for etoposide using β-d-galactosidase as a label

   • Tetsuya Saita
   • Kunio Fujiwara
   • Katsumi Takata

   Original Articles Pages: 115 - 120

9. A new intraperitoneal tumor model in the rat

   • J. D. Nagel
   • G. Los
   • J. G. McVie

   Original Articles Pages: 121 - 124

10. The effect of cimetidine on cyclophosphamide metabolism in rabbits

    • Lowell B. Anthony
    • Qi-cai Long
    • Kenneth R. Hande

    Original Articles Pages: 125 - 130

11. Phase I trial of 5-fluorouracil, leucovorin, and cisplatin in combination

    • Peter J. O'Dwyer
    • Mark J. Cornfeld
    • Robert L. Comis

    Original Articles Pages: 131 - 134

12. Intratumoural administration of cisplatin in slow-release devices

    • Marc J. M. Deurloo
    • Sieb Bohlken
    • Adrian C. Begg

    Original Articles Pages: 135 - 140

13. Cellular pharmacology of 1-β-d-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells

    • Richard L. Momparler
    • Nicole Onetto-Pothier
    • Louise F. Momparler

    Original Articles Pages: 141 - 146

14. Metabolism of epirubicin to glucuronides: relationship to the pharmacodynamics of the drug

    • Jacques Robert
    • Marc David
    • Corinne Granger

    Original Articles Pages: 147 - 150

15. A simplified assay for measurement of cytosine arabinoside incorporation into DNA in Ara-C-sensitive and-resistant leukemic cells

    • Louisa P. Colly
    • Dick J. Richel
    • Roel Willemze

    Original Articles Pages: 151 - 156

16. Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients

    • Guy G. Chabot
    • Lawrence E. Flaherty
    • Laurence H. Baker

    Original Articles Pages: 157 - 160

17. VIM-D salvage chemotherapy in Hodgkin's disease

    • Julia K. Phillips
    • Ruth L. Spearing
    • John R. Nash

    Original Articles Pages: 161 - 163

18. 7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia

    • Joseph D. Borsi
    • Erling Sagen
    • Peter J. Moe

    Short Communication Pages: 164 - 167

19. Hydroxyurea-induced acute alveolitis in a Patient with chronic myeloid leukaemia

    • Graham H. Jackson
    • Jonathon Wallis
    • Stephen J. Proctor

    Short Communication Pages: 168 - 169

20. Announcement

    Announcement Pages: 170 - 170